This report provides research summaries for Americas small-cap companies, including updates on GoodRx Holdings, MBX Biosciences, and a new initiation for WhiteFiber, Inc.
Key Takeaways
- 1.GoodRx Holdings rating remains Underweight due to limited visibility into the stabilization of its Prescription and Subscription businesses.
- 2.MBX Biosciences is viewed as having significant upside potential in obesity treatments with attention on upcoming 4Q data.
- 3.WhiteFiber, Inc. initiated at Equal Weight as an emerging AI infrastructure player with cloud and colocation services.
Table of Contents
- Americas Small Cap Research Summary
- GoodRx Holdings Inc.: Model Update: Business Model Continues To Transition but Limited Visibility
- MBX Biosciences: ENDO 2026 Preview: What are we looking for?
- WhiteFiber, Inc.: Interesting AI Infrastructure Play; Initiate at Equal Weight
Access the Full Report
Get unlimited access to institutional research reports with a 14-day free trial.
Authors
Glen SantangeloPeter WarendorfJenna DavidnerEliana MerleRaimo Lenschow
Securities
WYFIGDRXMBX
Themes
AI InfrastructureObesity Treatment Market
Regions
North AmericaUnited States